MARIMAR OTERO-ROJAS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health SALT LAKE CITY, UT NPI 1699347732
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health UT Retrophin, Inc. All categories
General Payments — all program years on this page
$890.71
- Category: General Payments
- Program years: PY2022–2023
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $128.03 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $128.03 | 6 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $55.67 | 2 |
| Horizon Pharma plc | $25.69 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $19.98 | 1 |
| Acerta Pharma LLC | $13.68 | 1 |
| GlaxoSmithKline, LLC. | $13.01 | 1 |
By program year
Records — PY2023 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1004219447 | GlaxoSmithKline, LLC. | $13.01 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1011498645 | AstraZeneca Pharmaceuticals LP | $13.68 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059612097 | Travere Therapeutics, Inc. | $23.32 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1059612101 | Travere Therapeutics, Inc. | $32.35 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987108675 | Horizon Therapeutics plc | $25.69 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 993479983 | Calliditas Therapeutics US Inc. | $19.98 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.